Insulin containing polyethylenimine–dextran sulfate nanoparticles
- 6 March 2003
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 255 (1-2) , 139-151
- https://doi.org/10.1016/s0378-5173(03)00055-3
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Formulation and characterization of amphotericin B–polyethylenimine–dextran sulfate nanoparticlesJournal of Pharmaceutical Sciences, 2001
- Formation of insulin amyloid fibrils followed by FTIR simultaneously with CD and electron microscopyProtein Science, 2000
- Estimation of the number of α‐helical and β‐strand segments in proteins using circular dichroism spectroscopyProtein Science, 1999
- Preparation Techniques and Mechanisms of Formation of Biodegradable Nanoparticles from Preformed PolymersDrug Development and Industrial Pharmacy, 1998
- Selective stability-indicating high-performance liquid chromatographic assay for recombinant human regular insulinJournal of Chromatography A, 1995
- Secondary Structure Characterization of Microparticulate Insulin Powders†Journal of Pharmaceutical Sciences, 1994
- Ionization of Poly(ethylenimine) and Poly(allylamine) at Various pH′sBioorganic Chemistry, 1994
- Biodegradable nanoparticles for subcutaneous administration of growth hormone releasing factor (hGRF)Journal of Controlled Release, 1992
- Conformational dynamics of insulin in solution. Circular dichroic studiesBiochemistry, 1980
- Interaction of sodium decyl sulfate with poly(L‐ornithine) and poly(L‐lysine) in aqueous solutionBiopolymers, 1976